.JPG?#)
Merck Q1 earnings: Gardasil sales hit by China market pressure
Sales of Merck’s HPV vaccine plummeted 41% in the first quarter, as the company continues to deal with lower demand in China. Gardasil is Merck’s second-biggest product behind its megablockbuster cancer drug Keytruda. First-quarter sales ...
Sales of Merck’s HPV vaccine plummeted 41% in the first quarter, as the company continues to deal with lower demand in China.
Gardasil is Merck’s second-biggest product behind its megablockbuster cancer drug Keytruda. First-quarter sales ...
